BR8001129A - Agente antitumor - Google Patents

Agente antitumor

Info

Publication number
BR8001129A
BR8001129A BR8001129A BR8001129A BR8001129A BR 8001129 A BR8001129 A BR 8001129A BR 8001129 A BR8001129 A BR 8001129A BR 8001129 A BR8001129 A BR 8001129A BR 8001129 A BR8001129 A BR 8001129A
Authority
BR
Brazil
Prior art keywords
antitumor agent
antitumor
agent
Prior art date
Application number
BR8001129A
Other languages
English (en)
Portuguese (pt)
Inventor
Yokokura Teruo
Mutai Masahiko
Kato Ikuo
Kobayashi Seizaburo
Original Assignee
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Kk filed Critical Yakult Honsha Kk
Publication of BR8001129A publication Critical patent/BR8001129A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR8001129A 1979-02-27 1980-02-26 Agente antitumor BR8001129A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2133979A JPS55113718A (en) 1979-02-27 1979-02-27 Antitumor agent

Publications (1)

Publication Number Publication Date
BR8001129A true BR8001129A (pt) 1980-11-04

Family

ID=12052351

Family Applications (1)

Application Number Title Priority Date Filing Date
BR8001129A BR8001129A (pt) 1979-02-27 1980-02-26 Agente antitumor

Country Status (12)

Country Link
US (1) US4347240A (OSRAM)
JP (1) JPS55113718A (OSRAM)
BR (1) BR8001129A (OSRAM)
CA (1) CA1124176A (OSRAM)
CH (1) CH653556A5 (OSRAM)
DE (1) DE3007412A1 (OSRAM)
FR (1) FR2450108B1 (OSRAM)
HK (1) HK23784A (OSRAM)
IT (1) IT1129802B (OSRAM)
MY (1) MY8500010A (OSRAM)
NL (1) NL189999C (OSRAM)
SG (1) SG38183G (OSRAM)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3125797A1 (de) * 1981-06-30 1983-01-13 Rudolf Dr. Schuler Diaetetisches mittel
US5965414A (en) * 1985-11-04 1999-10-12 Microlife Technics, Inc. Process for producing yeast and mold inhibiting products with lactobacillus
JPH0696538B2 (ja) * 1985-12-19 1994-11-30 株式会社アドバンス 抗発癌剤
WO1991005851A1 (en) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Bacterium strain lactobacillus casei subsp. casei 37 for production of a bacterial biological preparation
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
US7189834B2 (en) * 1993-05-11 2007-03-13 Marshall William E Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
WO1994026114A1 (en) * 1993-05-11 1994-11-24 Immunom Technologies, Inc. Method of stimulating and modulating the immune system of animals with microbial compositions
US6180100B1 (en) * 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
WO1997049820A1 (fr) 1996-06-26 1997-12-31 Kabushiki Kaisha Yakult Honsha Procedes de transfert de genes dans un chromosome
NZ337505A (en) * 1997-02-11 2001-07-27 Univ College Cork Nat Univ Ie Isolated antimicrobial agents from Lactobacillus salivarius
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
DE69832267T2 (de) * 1997-04-18 2006-08-10 Ganeden Biotech, Inc., La Jolla Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
WO2005000222A2 (en) * 2003-05-30 2005-01-06 Amylin Pharmaceuticals, Inc. Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins
CA2534013C (en) * 2003-07-30 2010-11-02 Bhph Company Limited Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection
US20050112097A1 (en) * 2003-11-26 2005-05-26 Hinton Golden S. Method for the treatment of cancer
CA2597229A1 (en) * 2005-02-11 2006-08-17 Technologie Biolactis Inc. Use of lactobacillus kefiranofaciens as a probiotic and a synbiotic
JPWO2008053588A1 (ja) * 2006-10-27 2010-02-25 株式会社ヤクルト本社 サイトカイン産生調節遺伝子及びその利用
WO2008053728A1 (en) * 2006-11-02 2008-05-08 Aureo Co., Ltd. Agent for promoting healing of living body
KR20100008831A (ko) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 락토바실러스 카제이 배양물을 유효성분으로 함유하는항암용 조성물
EP2498789B1 (en) 2009-11-11 2016-06-22 Alimentary Health Limited Probiotic bifidobacterium strain
ES2610829T3 (es) 2009-11-11 2017-05-03 Alimentary Health Limited Cepa de Bifidobacterium
WO2018158309A1 (en) 2017-02-28 2018-09-07 Alimentary Health Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
EP3601525B1 (en) 2017-03-23 2024-03-06 Universiteit Antwerpen Probiotic lactobacillus casei strain and its uses
EP4117697A1 (en) 2020-03-13 2023-01-18 PrecisionBiotics Group Limited Bifidobacterium longum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1514949A (fr) * 1965-06-01 1968-03-01 Texim Entpr Economique D Etat Procédé de fabrication d'une nouvelle substance à partir de culture de microorganisme du genre lactobacillus
US3632746A (en) * 1967-08-30 1972-01-04 Chugai Pharmaceutical Co Ltd Dried stable anti-tumor preparations and process for preparing the same
FR2244464A1 (en) * 1973-06-26 1975-04-18 Serozym Laboratoires Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc.

Also Published As

Publication number Publication date
NL189999B (nl) 1993-05-03
CH653556A5 (de) 1986-01-15
MY8500010A (en) 1985-12-31
IT1129802B (it) 1986-06-11
SG38183G (en) 1984-07-20
IT8067302A0 (it) 1980-02-27
NL189999C (nl) 1993-10-01
CA1124176A (en) 1982-05-25
FR2450108B1 (fr) 1988-10-28
JPS55113718A (en) 1980-09-02
US4347240A (en) 1982-08-31
DE3007412A1 (de) 1980-11-06
NL8001045A (nl) 1980-08-29
JPS6234727B2 (OSRAM) 1987-07-28
HK23784A (en) 1984-03-23
FR2450108A1 (fr) 1980-09-26

Similar Documents

Publication Publication Date Title
BR8001129A (pt) Agente antitumor
DK258477A (da) Kontrastmiddel
DK204981A (da) Serum-udskillende middel
BE882666A (fr) Lamellen-jaloezie met vertikaal aangebrachte lamellen
JPS52134027A (en) Antiitumor agent
JPS5325525A (en) Radiooopaque agent
BE882664A (fr) Lamellen-jaloezie met vertikaal aangebrachte lamellen
NO800164L (no) Roentgen-kontrastmiddel.
JPS5299230A (en) Antiitumor agent
JPS52118497A (en) Antiiallergy agent
JPS5297933A (en) Antiihypertensive agent
IT7850273A0 (it) Agente antitumorale
BE882665A (fr) Lamellen-jaloezie met vertikale lamellen
FR2350847A1 (fr) Agent immunostimulant
JPS535195A (en) Antiibacterial agent
AT355693B (de) Wasserverduennbares waermehaertendes ueberzugs- mittel
JPS52117436A (en) Antiicoccidium agent
IT1128169B (it) Agente antivirale cpmprendente 1-b-d-arabinofuranosil-timina
JPS5377055A (en) Antiilinoovirus agent
JPS5297963A (en) Antiihypertensive agent
JPS5372828A (en) Antiicancer agent
JPS5379012A (en) Antiicancer agent
JPS5297967A (en) Antiihypertensive agent
IT8419321A1 (it) Agente antitumorale
DK200180A (da) Fungicidt middel